SELLAS Life Sciences Group To Present At The 34th Annual J.P. Morgan Healthcare Conference On Tuesday, January 12, 2016 /PRNewswire/ — SELLAS Life Sciences Group , a development-stage biopharmaceutical company with its main focus on developing innovative products to treat cancers and central nervous system diseases, today announced that , M.D., Chief Executive Officer and Chairman of the Board, will present at the 34th Annual J.P. Morgan Healthcare Conference on , CA. Dr. Stergiou’s presentation will include a SELLAS Life Sciences Group corporate overview as well as clinical and business update.
